Litcius/Paper detail

The Biochemical and Genetic Basis for the Biosynthesis of Bioactive Compounds in Hypericum perforatum L., One of the Largest Medicinal Crops in Europe

Paride Rizzo, Lothar Altschmied, Beena M. Ravindran, Twan Rutten, John C. D’Auria

2020Genes63 citationsDOIOpen Access PDF

Abstract

produces several bioactive compounds, its importance is mainly linked to two molecules highly relevant for the pharmaceutical industry: the prenylated phloroglucinol hyperforin and the naphtodianthrone hypericin. The first functions as a natural antidepressant while the second is regarded as a powerful anticancer drug and as a useful compound for the treatment of Alzheimer's disease. While the antidepressant activity of SJW extracts motivate a multi-billion dollar industry around the world, the scientific interest centers around the biosynthetic pathways of hyperforin and hypericin and their medical applications. Here, we focus on what is known about these processes and evaluate the possibilities of combining state of the art omics, genome editing, and synthetic biology to unlock applications that would be of great value for the pharmaceutical and medical industries.

Topics & Concepts

Hypericum perforatumHypericumMedicinal plantsBiosynthesisBiologyBiotechnologyTraditional medicineBotanyMedicineBiochemistryGeneNatural Compound Pharmacology StudiesPlant Molecular Biology ResearchPlant tissue culture and regeneration
The Biochemical and Genetic Basis for the Biosynthesis of Bioactive Compounds in Hypericum perforatum L., One of the Largest Medicinal Crops in Europe | Litcius